![PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/da636fe1ddd6e8a21289ef039ca3fe546cdc0f89/2-Table2-1.png)
PDF] A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. | Semantic Scholar
![Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study | BMC Cancer | Full Text Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study | BMC Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-5224-6/MediaObjects/12885_2018_5224_Fig2_HTML.png)
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study | BMC Cancer | Full Text
![Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant - ATC Abstracts Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant - ATC Abstracts](https://atcmeetingabstracts.com/wp-content/uploads/2020/05/g5339_1.png)
Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant - ATC Abstracts
![Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target](https://www.endocrinepractice.org/cms/attachment/ced59f52-d44f-48cd-8ab6-f9d04ff64f12/gr1.jpg)
Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) targeted therapy run-in followed by triplet dosing with TECENTRIQ® (atezolizumab)
![Common estimates where justified and indirect comparisons of all BID or... | Download Scientific Diagram Common estimates where justified and indirect comparisons of all BID or... | Download Scientific Diagram](https://www.researchgate.net/publication/262940276/figure/fig3/AS:296513503809538@1447705736661/Common-estimates-where-justified-and-indirect-comparisons-of-all-BID-or-QD-dosing.png)
Common estimates where justified and indirect comparisons of all BID or... | Download Scientific Diagram
![2017 Guidelines for the management of heart failure by pharmacists - Lesley C. Beique, Justin A. Ezekowitz, Eileen O'Meara, Michael McDonald, Sheri L. Koshman, 2019 2017 Guidelines for the management of heart failure by pharmacists - Lesley C. Beique, Justin A. Ezekowitz, Eileen O'Meara, Michael McDonald, Sheri L. Koshman, 2019](https://journals.sagepub.com/cms/10.1177/1715163519853307/asset/images/large/10.1177_1715163519853307-fig1.jpeg)
2017 Guidelines for the management of heart failure by pharmacists - Lesley C. Beique, Justin A. Ezekowitz, Eileen O'Meara, Michael McDonald, Sheri L. Koshman, 2019
![Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King, Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King,](https://journals.sagepub.com/cms/10.1177/2045894020922814/asset/images/large/10.1177_2045894020922814-fig2.jpeg)
Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers - John S. Grundy, Christopher D. King,
![Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01632-2/MediaObjects/41416_2021_1632_Fig1_HTML.png)
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
![Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01489/article_deploy/html/images/pharmaceutics-13-01489-g001.png)
Pharmaceutics | Free Full-Text | Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
![Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13054-021-03568-8/MediaObjects/13054_2021_3568_Fig2_HTML.png)
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis | Critical Care | Full Text
![Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram](https://www.researchgate.net/publication/325372028/figure/fig1/AS:630331015172096@1527294033000/Patient-flow-diagram-BID-twice-daily-PK-pharmacokinetics-QD-once-daily.png)
Patient flow diagram. BID, twice daily; PK, pharmacokinetics; QD, once... | Download Scientific Diagram
![Frontiers | Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Frontiers | Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma](https://www.frontiersin.org/files/Articles/780798/fonc-11-780798-HTML-r1/image_m/fonc-11-780798-g001.jpg)
Frontiers | Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
![Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy | European Respiratory Society Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy | European Respiratory Society](https://erj.ersjournals.com/content/erj/36/3/524/F3.large.jpg)